Challenging AID Candidacy Norms

Hosted by Nancy Hanna

The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast.

Recorded live at the ADA Conference in Orlando, Florida 2024.Nancy Hanna is joined by Cari Berget MPH, RN, CDCES who is a Research Instructor of Pediatric Endocrinology at the University of Colorado School of Medicine – Barbara Davis Center.

During this episode, Nancy and Cari discuss automated insulin delivery (AID) candidacy and challenge the perception that people need to meet certain requirements to be considered for AID. Cari shares her experience prescribing diabetes technology to patients who typically might not been considered for automated insulin delivery and shows the progress and clinical benefits that some of her patients have experienced on Omnipod 5.

Time stamps

8:29 – Hear about some of the perceived barriers to adopting automated insulin delivery (AID) and how Cari addresses them
11:25 – Learn how Cari has challenged the perceptions of who is the appropriate AID patient and met with clinical success
13:29 – Does the perfect pump candidate exist?
16:26 – Can a patient who struggles to bolus still benefit from Omnipod 5?

 

See more episodes
This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.

Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.

The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older & type 2 diabetes in persons aged 18 years and older. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with NovoLog®, Humalog®, and Admelog®. Refer to the Omnipod 5 Automated Insulin Delivery System User Guide and www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions. Warning: DO NOT use SmartAdjust technology for individuals under 2 years of age or use less than 5 U of insulin per day. DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.